BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17852016)

  • 1. Alternative trial design in amyotrophic lateral sclerosis saves time and patients.
    Groeneveld GJ; Graf M; van der Tweel I; van den Berg LH; Ludolph AC
    Amyotroph Lateral Scler; 2007 Oct; 8(5):266-9. PubMed ID: 17852016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential designs for clinical trials in amyotrophic lateral sclerosis.
    Groeneveld GJ; van der Tweel I; Wokke JH; van den Berg LH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):202-7. PubMed ID: 15799547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of adaptive sample size adjustment with respect to stopping criteria and time of interim analysis.
    Jahn-Eimermacher A; Hommel G
    Stat Med; 2007 Mar; 26(7):1450-61. PubMed ID: 16900553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving efficiency of ALS clinical trials using lead-in designs.
    Moore DH; Miller RG
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():57-60. PubMed ID: 15512875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS.
    Levy G; Kaufmann P; Buchsbaum R; Montes J; Barsdorf A; Arbing R; Battista V; Zhou X; Mitsumoto H; Levin B; Thompson JL
    Neurology; 2006 Mar; 66(5):660-3. PubMed ID: 16534103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues in amyotrophic lateral sclerosis clinical trial design.
    Munsat TL
    Adv Neurol; 1995; 68():209-18. PubMed ID: 8787231
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeated confidence intervals for adaptive group sequential trials.
    Mehta CR; Bauer P; Posch M; Brannath W
    Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study duration for clinical trials with survival response and early stopping rule.
    Kim K; Tsiatis AA
    Biometrics; 1990 Mar; 46(1):81-92. PubMed ID: 2350572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible two-stage design with sample size reassessment for survival trials.
    Desseaux K; Porcher R
    Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing clinical trials in amyotrophic lateral sclerosis.
    Shefner JM
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):495-508, ix. PubMed ID: 18625412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining survival as an outcome measure in amyotrophic lateral sclerosis.
    Gordon PH; Corcia P; Lacomblez L; Pochigaeva K; Abitbol JL; Cudkowicz M; Leigh PN; Meininger V
    Arch Neurol; 2009 Jun; 66(6):758-61. PubMed ID: 19506136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC; Stephen Coad D
    Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conducting a cost-effectiveness trial in oncology: justification and method].
    Lejeune C; Binquet C; Bonnetain F
    Bull Cancer; 2009 May; 96(5):603-7. PubMed ID: 19435689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
    Tamura RN; Huang X
    Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.
    Leigh PN; Swash M; Iwasaki Y; Ludolph A; Meininger V; Miller RG; Mitsumoto H; Shaw P; Tashiro K; Van Den Berg L
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):84-98. PubMed ID: 15204010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis.
    Peysson S; Vandenberghe N; Philit F; Vial C; Petitjean T; Bouhour F; Bayle JY; Broussolle E
    Eur Neurol; 2008; 59(3-4):164-71. PubMed ID: 18230874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of restricted sequential design in a clinical protocol.
    Thompson EI
    Cancer Treat Rep; 1980; 64(2-3):399-403. PubMed ID: 7407776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design using historical controls.
    Yen A; Simpson E; Haverkamp L; Appel S
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():61-3. PubMed ID: 15512876
    [No Abstract]   [Full Text] [Related]  

  • 19. The design of clinical trials in amyotrophic lateral sclerosis.
    Azulay JP
    Adv Neurol; 1995; 68():225-7. PubMed ID: 8787233
    [No Abstract]   [Full Text] [Related]  

  • 20. Issues in the use of adaptive clinical trial designs.
    Emerson SS
    Stat Med; 2006 Oct; 25(19):3270-96; discussion 3302-4, 3320-5, 3326-47. PubMed ID: 16906553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.